Trading in options tied to Denali Therapeutics Inc. (NASDAQ:DNLI) jumped to a total of 2,291 contracts at 2:10 p.m. New York time on Thursday, according to exchange data compiled by Bloomberg.
The activity was dominated by calls, with call volume reaching 1,863 contracts and puts totaling 428 contracts. The most heavily traded single series was the July 17, 2026 $30 call, which accounted for 1,535 contracts. That series had an open interest of 10 contracts as of Wednesday.
On the equities side, Denali Therapeutics shares traded at $24.91, up 0.36% on the session. Market-implied measures showed rising uncertainty: three-month implied volatility increased by 17.02 percentage points to reach 86.41%. The three-month 90/110 skew also moved higher, climbing by 9.74 percentage points to 8.53 percentage points.
Context and market signals
The options flow for the session was concentrated in calls relative to puts, and a single call series represented a substantial share of the total contracts exchanged. At the same time, measures of short-term implied volatility and skew both rose, indicating increased pricing of asymmetric risk in the options market.
What the reported figures show
- Total option contracts traded: 2,291 (as of 2:10 p.m. New York time, Thursday).
- Call volume: 1,863 contracts; Put volume: 428 contracts.
- Largest single series: July 17, 2026 $30 call - 1,535 contracts traded; open interest was 10 contracts as of Wednesday.
- Share price movement: +0.36%, trading at $24.91.
- Three-month implied volatility: rose 17.02 percentage points to 86.41%.
- Three-month 90/110 skew: rose 9.74 percentage points to 8.53 percentage points.
The facts above reflect the exchange data and the market metrics reported for the day.